Transfection reagents differ considerably in transfection efficiency. Most reagents transfer DNA inefficiently as cells only take up particles of a specific size. In addition, most reagents cannot sufficiently protect the DNA-complex against endonuclease degradation. Our innovated carrier molecules allow the DNA-complexes to be taken up more efficiently, thus increasing the transfection rate.
Preoptimized transfection kits enable efficient delivery of siRNA, plasmid DNA, mRNA, and microRNA into broad range of cell types and primary cells. Advanced formulation of polymer, lipid, and dendrimer-based reagents supported by peculiar design of the transfection protocols.
Code | Product Specificity |
CLT-001 | African Green Monkey Kidney Cells |
CLT-002 | Aortic Smooth Muscle Cells |
CLT-003 | Bone Marrow Neuroblastoma Cells |
CLT-004 | Bone Marrow Stromal Cells |
CLT-005 | Breast Cancer Cells |
CLT-006 | Chromaffin Cell Cultures |
CLT-007 | Glioblastoma Cells |
CLT-008 | Hamster Ovary Epithelium Cells |
CLT-009 | Hamster Pancreatic Carcinoma Cells |
CLT-010 | Human Coronary Artery Endothelial Cells |
CLT-011 | Human Chondrocyte-like Cells |
CLT-012 | Human Cortical Neuronal Cells |
CLT-013 | Human Adrenocortical Carcinoma Cells |
CLT-014 | Human Breast Cancer Cells |
CLT-015 | Human Cervic Adenocarcinoma Cells |
CLT-016 | Human Colorectal Adenocarcinoma Cells |
CLT-017 | Human Diploid Fibroblast Cells |
CLT-018 | Human Epithelial Kidney Cells |
CLT-019 | Human Hepatocellular Carcinoma Cells |
CLT-020 | Human Hepatoma Cells |
CLT-021 | Human Hypopharyngeal Carcinoma Cells |
CLT-022 | Human Lung Carcinoma Cells |
CLT-023 | Human Mammary Epithelial Cancer Cells |
CLT-024 | Human Mouth Epidermal Carcinoma Cells |
CLT-025 | Human Neuroblastoma Cells |
CLT-026 | Human Neutroblastoma Cells |
CLT-027 | Human Osteosarcoma Cells |
CLT-028 | Human Osteoblastic Cells |
CLT-029 | Human Pancreatic Cells |
CLT-030 | Human Prostate Cancer Cells |
CLT-031 | Human Renin-Expressing Cells |
CLT-032 | Human Rhabdomyosarcoma Cells |
CLT-033 | Human Pancreatic Cancer Cells |
CLT-034 | Human Prostate Cancer Cells |
CLT-035 | Human Trachea Epithelium Cells |
CLT-036 | Human Tracheal Gland Cells |
CLT-037 | Keratinocyte Cells |
CLT-038 | Leydig Tumor Cells |
CLT-039 | Monkey Kidney Cells |
CLT-040 | Mouse Embryonic Stem Cells |
CLT-041 | Mouse Fibroblast Cells |
CLT-042 | Murine Embryonic Fibroblast Cells |
CLT-043 | Murine Fibroblast Cells |
CLT-044 | Murine Fibrosarcoma Cells |
CLT-045 | Murine Lewis Lung Carcinoma Cells |
CLT-046 | Murine Macrophage Cells |
CLT-047 | Murine Mastocytoma Cells |
CLT-048 | Neuroblastoma Cells |
CLT-049 | Normal Rat Kidney Epithelial Cells |
CLT-050 | Primary Astrocyte Cells |
CLT-051 | Primary Fibroblast Cells |
CLT-052 | Primary Hepatocarcinoma Cells |
CLT-053 | Prostate Cancer Cells |
CLT-054 | Prostate Smooth Muscle Cells |
CLT-055 | Porcine Aortic Endothelial Cells |
CLT-056 | Rat Brain Astrocyte Cells |
CLT-057 | Rat Pheochromocytoma Cells |
CLT-058 | Renal Carcinoma Cells |
CLT-059 | Retinal Pigment Epithelial Cells |
CLT-060 | Retinoblastoma Cells |
CLT-061 | Umbilical Vein Endothelial Cells |